KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme Group (CME) Change in Cash: 2009-2024

Historic Change in Cash for Cme Group (CME) over the last 16 years, with Dec 2024 value amounting to $8.7 billion.

  • Cme Group's Change in Cash fell 48.68% to $7.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $49.7 billion, marking a year-over-year increase of 304.52%. This contributed to the annual value of $8.7 billion for FY2024, which is 119.36% up from last year.
  • Latest data reveals that Cme Group reported Change in Cash of $8.7 billion as of FY2024, which was up 119.36% from -$44.9 billion recorded in FY2023.
  • Cme Group's 5-year Change in Cash high stood at $72.4 billion for FY2021, and its period low was -$44.9 billion during FY2023.
  • Moreover, its 3-year median value for Change in Cash was -$22.8 billion (2022), whereas its average is -$19.7 billion.
  • As far as peak fluctuations go, Cme Group's Change in Cash spiked by 2,363.96% in 2020, and later slumped by 131.53% in 2022.
  • Cme Group's Change in Cash (Yearly) stood at $49.8 billion in 2020, then spiked by 45.36% to $72.4 billion in 2021, then slumped by 131.53% to -$22.8 billion in 2022, then tumbled by 96.64% to -$44.9 billion in 2023, then soared by 119.36% to $8.7 billion in 2024.